Search is Powered by Google
Cancer / Oncology News

USC School Of Dentistry Researchers Discover Link Between Oral Cancer And Ethnicity

Main Category: Cancer / Oncology
Article Date: 14 Nov 2007 - 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Clinicians from the USC School of Dentistry unravel connection between the incidence of oral cancer and race and ethnicity-- as part of first epidemiological study of oral cancer in California. Dr. Satish Kumar and Dr.Parish Sedghizadeh, clinical professors in the school's Division of Diagnostic Sciences, gleaned through 20 years of records from the California Cancer Registry (CCR)-the state's cancer surveillance database-for the incidence rates of invasive squamous cell carcinoma, the most common form of oral cancer.

Their findings will be published in an upcoming issue of the journal Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology and are currently available online at http://www.ooooe.net.

Kumar and Sedghizadeh theorized that groups who engaged in these high-risk behaviors would also experience higher rates of oral cancer. The researchers discovered that different ethnic groups living in California manifest the disease very differently. African Americans and Caucasians, who have the highest oral cancer rates, are most likely to develop cancer of the tongue. Among Asian populations, Koreans had the highest incidence of tongue cancer, while Southeast Asians were more likely to develop the disease in the buccal mucosa, or inner cheek. Filipino women have the highest incidence of cancer of the palate.

The research team theorized that cultural habits are to blame. From what we know of how the cancer develops, we can extrapolate that cultural habits and lifestyle choices are directly linked to the prevalence of oral cancer in certain groups," Kumar says. They were right.

For example, African American and Caucasian men, with the highest rates of cancer of the tongue, also have the highest rates of cigarette smoking in the state. In Asian groups, Koreans have the highest cigarette smoking rates. The practice of chewing tobacco, or areca nut, most common in South Asian cultures, may account for that group's likelihood of developing the disease in the inner cheek. The high rate of palatial cancer among Filipino women could be attributed to the practice of reverse smoking, when the lit part of the cigarette is concealed inside the mouth "Smoking is still considered taboo among Philippine women," Sedghizadeh says. "The lit part of the cigarette contains the most carcinogens and if held near the palate, could account for these statistics."

Up to two-thirds of oral cancers are caused by tobacco or alcohol use, according to the Oral Cancer Foundation. Though the cancer will claim the lives of 7,500 Americans this year, it is the most diagnosed cancer in many developing countries-including India, China and Vietnam-where its populations engage in these high-risk behaviors.

The study represents the first effort to analyze the epidemiology of oral cancer from statistics gathered by the CCR. "Basically we had a trove of information that had never before been accessed," says Sedghizadeh. "People have looked at breast and prostate and other types of cancers, but no one had mined this field for oral cancer statistics."

The research team hopes their findings can help tailor oral cancer prevention messages aimed at particular ethnic groups. "If we are aware that certain subsets are getting a particular kind of oral cancer, we can develop educational materials tailored to that particular risk activity and that particular group," Sedghizadeh says. "Ultimately we realize that need to increase awareness not just for the individual," Kumar says, "but for their entire community as well.

Cancer incidence data used in this report have been collected by the California Cancer Registry of the California Department of Health Services as part of the statewide cancer reporting program, mandated by California Health and Safety Code Section 210 and 211.3. Support has also been provided by the Division of Cancer Prevention and Control, National Cancer Institute, U.S. Department of Health and Human Services, under contract N02-PC-15105, the Centers for Disease Control and Prevention National Program of Cancer Registries under contract U75/CCU910677, the Tobacco Tax and Health Promotion Act of 1988 and the Breast Cancer Act of 1993.

http://www.usc.edu




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...